Penta-O-galloyl-β-D-glucose inhibits phorbol myristate acetate-induced intereukin-8 gene expression in human monocytic U937 cells through its inactivation of nuclear factor-κB

International Immunopharmacology

Volumn 4, Issue 3, 2004, Pages 377-386

  Oh, G S ^a   Pae, H O ^a   Choi, B M ^a   Lee, H S ^b   Kim, I K ^b   Yun, Y G ^b   Kim, J D ^b   Chung, H T ^a  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

I B ; Interleukin 8; Nuclear factor B; Paeonia suffruticosa; Penta O galloyl D glucose

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PENTA O GALLOYL BETA DEXTRO GLUCOSE; PHORBOL 13 ACETATE 12 MYRISTATE; TANNIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MONOCYTE; PAEONIA SUFFRUTICOSA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; HYDROLYZABLE TANNINS; I-KAPPA B PROTEINS; INTERLEUKIN-8; NF-KAPPA B; PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; U937 CELLS;

EID: 1642386899     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.10.010     Document Type: Article

References (23)

1. Biasi D., Carletto A., Caramaschi P., Bellavite P., Maleknia T., Scambi C.et al. Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis. Inflammation. 22:1998;533-543.
2. Zeilhofer H.U., Schorr W. Role of interleukin-8 in neutrophil signaling. Curr. Opin. Hematol. 7:2000;178-182.
3. Salgado A., Boveda J.L., Monasterio J., Segura R.M., Mourelle M., Gomez-Jimenez J.et al. Inflammatory mediators and their influence on haemostasis. Haemostasis. 24:1994;132-138.
4. Strieter R.M., Koch A.E., Antony V.B., Fick R.B. Jr., Standiford T.J., Kunkel S.L. The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J. Lab. Clin. Med. 123:1994;183-197.
5. Roebuck K.A. Regulation of interleukin-8 gene expression. J. Interferon. Cytokine. Res. 19:1999;429-438.
6. Wang J.M., Deng X., Gong W., Su S. Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods. 220:1998;1-17.
7. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 3:2002;221-227.
8. Geetha T., Wooten M.W. Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett. 512:2002;19-24.
9. Tsoulfas G., Geller D.A. NF-kappaB in transplantation: friend or foe? Transpl. Infect. Dis. 3:2001;212-219.
10. Palanki M.S. Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Curr. Med. Chem. 9:2002;219-227.
11. Shin W.S., Szuba A., Rockson S.G. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis. 160:2002;91-102.
12. Umezawa K., Ariga A., Matsumoto N. Naturally occurring and synthetic inhibitors of NF-kappaB functions. Anticancer Drug Des. 15:2000;239-244.
13. Roebuck K.A. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int. J. Mol. Med. 4:1999;223-230.
14. Roebuck K.A. Regulation of interleukin-8 gene expression. J. Interferon. Cytokine Res. 19:1999;429-438.
15. Okubo T., Nagai F., Seto T., Satoh K., Ushiyama K., Kano I. The inhibition of phenylhydroquinone-induced oxidative DNA cleavage by constituents of Moutan cortex and Paeoniae radix. Biol. Pharm. Bull. 23:2000;199-203.
16. Ono K., Sawada T., Murata Y., Saito E., Iwasaki A., Arakawa Y.et al. Pentagalloylglucose, an antisecretory component of Paeoniae radix, inhibits gastric H+K(+)-ATPase. Clin. Chim. Acta. 290:2000;159-167.
17. Satoh K., Nagai F., Ushiyama K., Yasuda I., Seto T., Kano I. Inhibition of Na+,K(+)-ATPase by 1,2,3,4,6-penta-O-galloyl-β-D-glucose, a major constituent of both Moutan cortex and Paeoniae radix. Biochem. Pharmacol. 53:1997;611-614.
18. Oh G.S., Pae H.O., Oh H., Hong S.G., Kim I.K., Chai K.Y.et al. In vitro anti-proliferative effect of 1,2,3,4,6-penta-O-galloyl-β-D-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett. 174:2001;17-24.
19. Pan M.H., Lin-Shiau S.Y., Ho C.T., Lin J.H., Lin J.K. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem. Pharmacol. 59:2000;357-367.
20. Zhang X., Wang J.M., Gong W.H., Mukaida N., Young H.A. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. J. Immunol. 166:2001;7104-7111.
21. Garcia J.E., de Cabo M.R., Rodriguez F.M., Losada J.P., Lopez A.J., Arellano J.L. Effect of cyclosporin A on inflammatory cytokine production by U937 monocyte-like cells. Mediators Inflamm. 9:2000;169-174.
22. Genin P., Mamane Y., Kwon H., LePage C., Wainberg M.A., Hiscott J. Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells. Virology. 261:1999;205-215.
23. Miller E.J., Nagao S., Carr F.K., Noble J.M., Cohen A.B. Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin a (SEA). Inflamm. Res. 45:1996;386-392.